Last updated: April 3, 2025
Sponsor: Kaplan Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
White Cell Disorders
Neutropenia
Treatment
Cord blood
Clinical Study ID
NCT06908616
KMC-24-0090
KMC-24-0090
Ages 1-1 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025
Parental informed consent obtained
Umbilical cord blood available for routine testing
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Cord blood
Phase:
Study Start date:
October 08, 2024
Estimated Completion Date:
December 31, 2027
Study Description
Connect with a study center
Kaplan Medical Center
Rehovot, 7661041
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.